Stock Events

Stock Events

AB Corporate Bond 

$35.24
54
+$0.11+0.33% Tuesday 15:05

Statistics

Day High
35.22
Day Low
35.22
52W High
36.58
52W Low
34.59
Volume
37
Avg. Volume
-
Mkt Cap
129.61M
P/E Ratio
-
Dividend Yield
4.96%
Dividend
1.75

Upcoming

6
MAY
Dividend Payment
Decreased
 
1
JUN
Dividend Ex
Estimated
 
4
JUN
Dividend Payment
Estimated
 
1
JUL
Dividend Ex
Estimated
 
7
JUL
Dividend Payment
Estimated
 

Expense Ratio

0.30%
0%
1%+
The annual fee that you pay to the fund company for managing your investment. The lower the expense ratio, the better. This is not an investment recommendation.

Dividends

4.96%Dividend Yield
Jun 26
$0.15
May 26
$0.14
Apr 26
$0.14
Mar 26
$0.14
Feb 26
$0.14
10Y Growth
N/A
5Y Growth
N/A
3Y Growth
28.6%
1Y Growth
-1.07%

Earnings

8MayExpected
Q1 2024
Q2 2024
Q3 2024
Q1 2025
Q2 2025
Q3 2025
Next
-0.86
0.57
1.99
3.42
Expected EPS
-0.71
Actual EPS
N/A

Financials

22.44%Profit Margin
Profitable
2019
2020
2021
2022
2023
2024
32.04MRevenue
7.19MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow EYEG. It's not an investment recommendation.
Alphabet
79493
GOOGL
Apple
69146
AAPL
Microsoft
64576
MSFT
Amazon
60260
AMZN

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Regeneron Pharmaceuticals
REGN
Mkt Cap73.54B
Regeneron Pharmaceuticals competes in the development of treatments for eye diseases, directly competing with Kiora's focus on ophthalmic diseases.
Novavax
NVAX
Mkt Cap1.32B
Novavax, while primarily known for vaccines, is expanding into therapeutic areas that could overlap with Kiora's research interests.
Bausch Health Companies
BHC
Mkt Cap2.11B
Bausch Health Companies, through its eye health division, competes in the same ophthalmic market as Kiora Pharmaceuticals.
Biogen
BIIB
Mkt Cap27.62B
Biogen's expansion into therapies for neurological conditions includes research into diseases that can affect vision, overlapping with Kiora's interests.
Abbvie
ABBV
Mkt Cap365.43B
AbbVie, through its acquisition of Allergan, has a strong presence in the ophthalmology sector, competing with Kiora Pharmaceuticals.
Pfizer
PFE
Mkt Cap149.77B
Pfizer has a diverse portfolio that includes treatments for conditions potentially overlapping with Kiora's focus areas.
Johnson & Johnson
JNJ
Mkt Cap546.9B
Johnson & Johnson, through its pharmaceuticals and medical devices divisions, competes in various healthcare sectors, including eye health.
Novartis
NVS
Mkt Cap279.67B
Novartis has a significant ophthalmology division, directly competing with Kiora Pharmaceuticals in developing treatments for eye diseases.

About

An actively managed investment-grade corporate bond ETF that seeks to maximize total return through current income and long-term capital appreciation
Show more...
CEO
Country
United States
ISIN
US00039J8633

Listings

STU
DE
7EY.STU
MU
DE
7EY.MU
F
DE
7EY.F
BOATS
BOATS
KPRX.BOATS

0 Comments

Share your thoughts

FAQ

What is AB Corporate Bond stock price today?▼
The current price of EYEG is $35.24 USD — it has increased by +0.33% in the past 24 hours. Watch AB Corporate Bond stock price performance more closely on the chart.
What is AB Corporate Bond stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange AB Corporate Bond stocks are traded under the ticker EYEG.
Is AB Corporate Bond stock price growing?▼
EYEG stock has fallen by -0.09% compared to the previous week, the month change is a -0.08% fall, over the last year AB Corporate Bond has showed a +1.09% increase.
What is AB Corporate Bond market cap?▼
Today AB Corporate Bond has the market capitalization of 129.61M
When is the next AB Corporate Bond earnings date?▼
AB Corporate Bond is going to release the next earnings report on May 08, 2026.
What were AB Corporate Bond earnings last quarter?▼
EYEG earnings for the last quarter are 0.01 USD per share, whereas the estimation was -0.74 USD resulting in a +101.36% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is AB Corporate Bond revenue for the last year?▼
AB Corporate Bond revenue for the last year amounts to 32.04M USD.
What is AB Corporate Bond net income for the last year?▼
EYEG net income for the last year is 7.19M USD.
Does AB Corporate Bond pay dividends?▼
Yes, EYEG dividends are paid monthly. The last dividend per share was 0.14 USD. As of today, Dividend Yield (FWD)% is 4.96%.
In which sector is AB Corporate Bond located?▼
AB Corporate Bond operates in the Other sector.
When did AB Corporate Bond complete a stock split?▼
The last stock split for AB Corporate Bond was on June 11, 2024 with a ratio of 1:9.